MAPLE PLAIN, Minn.--()--Proto Labs, Inc. (NYSE: PRLB), a leading online and technology-enabled quick-turn manufacturer, announces the availability of several additional high temperature resins through its Protomold injection molding service.
“These additional materials complement the hundreds of existing engineering-grade resins we currently offer, and allow us to make a wider variety of parts for our customers.”
Beginning today, customers can upload their 3D CAD model at the Protomold website www.protomold.com, and have quick-turn injection molded parts made in a variety of high temperature resins including Ultem™ (PEI) and PEEK. Parts made from these resins are often used in medical/healthcare and food contact applications. Customers uploading parts will quickly receive back an interactive ProtoQuote, from which they can easily place an order.
“We’re excited to announce the addition of these high-performance resins to our Protomold service,” says Brad Cleveland, President and CEO. “These additional materials complement the hundreds of existing engineering-grade resins we currently offer, and allow us to make a wider variety of parts for our customers.”
About Proto Labs, Inc.
Proto Labs is a leading online and technology-enabled quick-turn manufacturer of custom parts for prototyping and short-run production. Proto Labs provides “Real Parts, Really Fast” to product developers worldwide. Proto Labs utilizes computer numerical control (CNC) machining and injection molding to manufacture custom parts for our customers. For more information, visit protolabs.com.
Ultem™ is a trademark of SABIC.
Cautionary Note Regarding Forward-Looking Statements
Statements contained in this press release regarding matters that are not historical facts are “forward-looking statements” within the meaning of The Private Securities Litigation Reform Act of 1995. These statements involve known and unknown risks, uncertainties and other factors which may cause the results of Proto Labs to be materially different than those expressed or implied in such statements. Certain of these risk factors and others are described in the “Risk Factors” section of the final prospectus relating to the initial public offering, as filed with the SEC, as well as in Proto Labs’ subsequent reports filed with the SEC. Other unknown or unpredictable factors also could have material adverse effects on Proto Labs’ future results. The forward-looking statements included in this press release are made only as of the date hereof. Proto Labs cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, Proto Labs expressly disclaims any intent or obligation to update any forward-looking statements to reflect subsequent events or circumstances.